Study questions the value of intensive cardiac surveillance in cancer patients treated with anthracyclines. A study led by investigators at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) suggests that intensive cardiac surveillance programs routinely used for lymphoma patients with low to moderate cardiovascular risk who are treated with anthracyclines may have limited clinical value.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: A study led by investigators at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) suggests that intensive cardiac surveillance programs routinely used for lymphoma patients with low to moderate cardiovascular risk who are treated with anthracyclines may have limited clinical value.
- Ponto de atenção: study.
- Ponto de atenção: questions.
- Ponto de atenção: value.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
